The luteinizing hormone releasing hormone (lhrh) agonists market is segmented by drug type into Eligard, Zoladex, Lupron, Vantas and others. Amongst these segments, the Eligard segment is projected to grab a significant market share in the year 2021. The growth of the segment can be attributed to the rising usage of the drug for the treatment of prostate cancer.
Our in-depth analysis of the global market includes the following segments:
By Drug Type |
|
By Patient Type |
|
By End Users |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?